Genfit (GNFTF) - OTCPK - Current
  • Gery Divry | Send Message 15 Mar

    $GNFTF $ICPT .. The NASH RACE ... switching leaders http://bit.ly/1M5cL7q here is a animation of the race
    Reply
      • Logribel Biostocks | Send Message 16 Feb

        Genfit's NASH Phase 2b Results Are Published And Confirm The Biotech's Lead $GNFTF http://seekingalpha.com/a/2bkmg
        Reply
          • everywhe | Send Message 11 Feb

            $ICPT $GNFTF $GILD GENFIT- Gastroenterology: Press release tonight after market closes
            Reply (1)
            • everywhe | Send Message 11 Feb
              • Logribel Biostocks | Send Message 6 Jan

                Phase 3 NASH Trials: Genfit's Drug Will Beat Intercept's OCA To Market $GNFTF, $ICPT http://seekingalpha.com/a/2845m
                Reply
                  • everywhe | Send Message 16 Nov 2015

                    $GNFTF $ICPT $GILD GENFIT announces pivotal phase 3 clinical trial of #Elafibranor in #NASH following regulatory input: http://ow.ly/UGD4v
                    Reply
                      • everywhe | Send Message 12 Nov 2015

                        $ICPT $GNFTF SEC Short Sale Rule 201 Continued : $ICPT (NASDAQ
                        Reply
                          • everywhe | Send Message 12 Nov 2015
                            Reply
                              • Bhavneesh Sharma | Send Message 12 Nov 2015

                                Recent Developments In Non-Alcoholic Steatohepatitis (NASH): Genfit $GNFTF http://seekingalpha.com/a/26ur6
                                Reply
                                  • everywhe | Send Message 30 Oct 2015
                                    Reply
                                      • Logribel Biostocks | Send Message 17 Sep 2015

                                        NASH Drugs Update: Intercept's Phase 3 Details, Genfit's Diagnostic Tool And Raptor's Failure $ICPT, $GNFTF http://seekingalpha.com/a/23a3i
                                        Reply
                                          Company Description
                                          Genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.
                                          Country: France